These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7661885)

  • 21. Identification of defective binding of low density lipoprotein by the U937 proliferation assay in German patients with familial defective apolipoprotein B-100.
    Schewe CK; Schuster H; Hailer S; Wolfram G; Keller C; Zöllner N
    Eur J Clin Invest; 1994 Jan; 24(1):36-41. PubMed ID: 8187806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of species of low-density lipoprotein with defective clearance in patients with primary moderate hypercholesterolaemia.
    Vega GL; Grundy SM
    J Intern Med; 1992 Nov; 232(5):405-13. PubMed ID: 1453124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.
    Raal FJ; Pilcher G; Rubinsztein DC; Lingenhel A; Utermann G
    Atherosclerosis; 1997 Feb; 129(1):97-102. PubMed ID: 9069523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased production of HDL ApoA-I in homozygous familial defective ApoB-100.
    Schaefer JR; Winkler K; Schweer H; Hoffmann MM; Soufi M; Scharnagl H; Maisch B; Wieland H; Steinmetz A; März W
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1796-9. PubMed ID: 10894819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial defective apolipoprotein B100: clinical characteristics of 54 cases.
    Rauh G; Keller C; Kormann B; Spengel F; Schuster H; Wolfram G; Zöllner N
    Atherosclerosis; 1992 Feb; 92(2-3):233-41. PubMed ID: 1632851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemia.
    Schmidt HH; Stuhrmann M; Shamburek R; Schewe CK; Ebhardt M; Zech LA; Büttner C; Wendt M; Beisiegel U; Brewer HB; Manns MP
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2167-74. PubMed ID: 9626156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations.
    Rabacchi C; Bigazzi F; Puntoni M; Sbrana F; Sampietro T; Tarugi P; Bertolini S; Calandra S
    J Clin Lipidol; 2016; 10(4):944-952.e1. PubMed ID: 27578127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypocholesterolaemic effects of lovastatin in familial defective apolipoprotein B-100.
    Illingworth DR; Vakar F; Mahley RW; Weisgraber KH
    Lancet; 1992 Mar; 339(8793):598-600. PubMed ID: 1347103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
    Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M
    Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a heterozygous compound individual with familial hypercholesterolemia and familial defective apolipoprotein B-100.
    Rauh G; Schuster H; Fischer J; Keller C; Wolfram G; Zöllner N
    Klin Wochenschr; 1991 May; 69(7):320-4. PubMed ID: 2067318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.
    Gaffney D; Forster L; Caslake MJ; Bedford D; Stewart JP; Stewart G; Wieringa G; Dominiczak M; Miller JP; Packard CJ
    Atherosclerosis; 2002 May; 162(1):33-43. PubMed ID: 11947895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Physiology and pathophysiology of the metabolism of lipoproteins].
    Sandhofer F
    Wien Med Wochenschr; 1994; 144(12-13):286-90. PubMed ID: 8650930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for familial defective apolipoprotein B-100 with improved U937 monocyte proliferation assay.
    Van den Broek AJ; Hollaar L; Schaefer HI; Van der Laarse A; Schuster H; Defesche JC; Kastelein JJ; Van 't Hooft FM
    Clin Chem; 1994 Mar; 40(3):395-9. PubMed ID: 8131274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hereditary changes of apolipoproteins B and E].
    Gaeta G; Effuso L; Maurea N; Boccalatte M; Antignano A; Sifola C; Scala R
    Clin Ter; 1994 Jun; 144(6):527-37. PubMed ID: 8001338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exon skipping of hepatic APOB pre-mRNA with splice-switching oligonucleotides reduces LDL cholesterol in vivo.
    Disterer P; Al-Shawi R; Ellmerich S; Waddington SN; Owen JS; Simons JP; Khoo B
    Mol Ther; 2013 Mar; 21(3):602-9. PubMed ID: 23319054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
    Brugger D; Schuster H; Zöllner N
    Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial ligand-defective apolipoprotein B-100: detection, biochemical features and haplotype analysis of the R3531C mutation in the UK.
    Wenham PR; Henderson BG; Penney MD; Ashby JP; Rae PW; Walker SW
    Atherosclerosis; 1997 Mar; 129(2):185-92. PubMed ID: 9105560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia.
    Moorjani S; Roy M; Torres A; Bétard C; Gagné C; Lambert M; Brun D; Davignon J; Lupien P
    Lancet; 1993 May; 341(8856):1303-6. PubMed ID: 8098448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atherogenic lipoproteins resulting from genetic defects of apolipoproteins B and E.
    Weisgraber KH; Innerarity TL; Rall SC; Mahley RW
    Ann N Y Acad Sci; 1990; 598():37-48. PubMed ID: 2248450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phagocytic degradation of chylomicron remnants by fibroblasts from subjects with homozygous familial hypercholesterolaemia.
    YU KC; Smith D; Yamamoto A; Kawaguchi A; Harada-Shiba M; Yamamura T; Mamo JC
    Clin Sci (Lond); 1997 Feb; 92(2):197-203. PubMed ID: 9059322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.